QINGSONG HEALTH Shares Surge Nearly 8% in Morning Session Following AI Product Integration

Stock News05-04

QINGSONG HEALTH (02661) saw its shares rise close to 8% during the morning trading session. At the time of writing, the stock was up 7.05%, trading at HKD 56.2, with a turnover of HKD 30.23 million. The increase follows the company's recent announcement that its self-developed AI-powered evidence-based medicine agent, named "Zheng Yuanfang," has been officially integrated into the "Yilu Qingsong" service platform for doctors and medical professionals. This marks a product-level integration of the group's proprietary medical AI capabilities with its own physician service network. Public data shows that as of March 31, 2026, the "Yilu Qingsong" platform, empowered by "Zheng Yuanfang," had reached 69,615 medical professional users, representing a year-on-year increase of 46.4%. Among these users, 36,678 were associate chief physicians or higher, accounting for approximately 52.7% of the total and growing 42.7% year-on-year. The platform also had 3,672 ophthalmology professionals, a surge of 171.0% compared to the previous year. The company has established a three-tier AI framework consisting of the "Stellar Cloud Digital Base," the "Dr. GPT specialized medical large language model," and the "Zheng Yuanfang series of evidence-based medicine agents."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128567072?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 10:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128567072","market":"sg","top_or_hot":-1,"title":"QINGSONG HEALTH Shares Surge Nearly 8% in Morning Session Following AI Product Integration","media":"Stock News","content":"<p>QINGSONG HEALTH (02661) saw its shares rise close to 8% during the morning trading session. At the time of writing, the stock was up 7.05%, trading at HKD 56.2, with a turnover of HKD 30.23 million. The increase follows the company's recent announcement that its self-developed AI-powered evidence-based medicine agent, named \"Zheng Yuanfang,\" has been officially integrated into the \"Yilu Qingsong\" service platform for doctors and medical professionals. This marks a product-level integration of the group's proprietary medical AI capabilities with its own physician service network. Public data shows that as of March 31, 2026, the \"Yilu Qingsong\" platform, empowered by \"Zheng Yuanfang,\" had reached 69,615 medical professional users, representing a year-on-year increase of 46.4%. Among these users, 36,678 were associate chief physicians or higher, accounting for approximately 52.7% of the total and growing 42.7% year-on-year. The platform also had 3,672 ophthalmology professionals, a surge of 171.0% compared to the previous year. The company has established a three-tier AI framework consisting of the \"Stellar Cloud Digital Base,\" the \"Dr. GPT specialized medical large language model,\" and the \"Zheng Yuanfang series of evidence-based medicine agents.\"</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QINGSONG HEALTH Shares Surge Nearly 8% in Morning Session Following AI Product Integration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQINGSONG HEALTH Shares Surge Nearly 8% in Morning Session Following AI Product Integration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-04 10:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>QINGSONG HEALTH (02661) saw its shares rise close to 8% during the morning trading session. At the time of writing, the stock was up 7.05%, trading at HKD 56.2, with a turnover of HKD 30.23 million. The increase follows the company's recent announcement that its self-developed AI-powered evidence-based medicine agent, named \"Zheng Yuanfang,\" has been officially integrated into the \"Yilu Qingsong\" service platform for doctors and medical professionals. This marks a product-level integration of the group's proprietary medical AI capabilities with its own physician service network. Public data shows that as of March 31, 2026, the \"Yilu Qingsong\" platform, empowered by \"Zheng Yuanfang,\" had reached 69,615 medical professional users, representing a year-on-year increase of 46.4%. Among these users, 36,678 were associate chief physicians or higher, accounting for approximately 52.7% of the total and growing 42.7% year-on-year. The platform also had 3,672 ophthalmology professionals, a surge of 171.0% compared to the previous year. The company has established a three-tier AI framework consisting of the \"Stellar Cloud Digital Base,\" the \"Dr. GPT specialized medical large language model,\" and the \"Zheng Yuanfang series of evidence-based medicine agents.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AGIX","symbol_name":"通用人工智能 ETF-AGIX","start_time":0,"source_url":"","article_id":"1128567072","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128567072","pubTimestamp":1777861344,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"QINGSONG HEALTH (02661) saw its shares rise close to 8% during the morning trading session. At the time of writing, the stock was up 7.05%, trading at HKD 56.2, with a turnover of HKD 30.23 million....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AGIX":"通用人工智能 ETF-AGIX","ARTY":"ISHARES FUTURE AI & TECH ETF","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK4585":"ETF&股票定投概念","VXUS":"国际股票ETF-Vanguard","BK1219":"保健护理服务","BK4588":"碎股","02661":"轻松健康","AIPO":"Defiance AI and Power Infrastructure ETF"},"translate_title":"AI产品整合后，青松健康早盘股价飙升近8%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02661":1,"AGIX":1,"AIPO":1,"CHAT":1,"VXUS":1,"ARTY":1},"content_text":"QINGSONG HEALTH (02661) saw its shares rise close to 8% during the morning trading session. At the time of writing, the stock was up 7.05%, trading at HKD 56.2, with a turnover of HKD 30.23 million. The increase follows the company's recent announcement that its self-developed AI-powered evidence-based medicine agent, named \"Zheng Yuanfang,\" has been officially integrated into the \"Yilu Qingsong\" service platform for doctors and medical professionals. This marks a product-level integration of the group's proprietary medical AI capabilities with its own physician service network. Public data shows that as of March 31, 2026, the \"Yilu Qingsong\" platform, empowered by \"Zheng Yuanfang,\" had reached 69,615 medical professional users, representing a year-on-year increase of 46.4%. Among these users, 36,678 were associate chief physicians or higher, accounting for approximately 52.7% of the total and growing 42.7% year-on-year. The platform also had 3,672 ophthalmology professionals, a surge of 171.0% compared to the previous year. The company has established a three-tier AI framework consisting of the \"Stellar Cloud Digital Base,\" the \"Dr. GPT specialized medical large language model,\" and the \"Zheng Yuanfang series of evidence-based medicine agents.\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128567072","isCrawlerRequest":true}